Search research articles
Contact Us
Filters
Showing results (231-240 of 332) with videos related to
Page
of 34
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
June 14, 2025
Current status of adjuvant immunotherapy and relapse management in renal cell carcinoma: Insights from a European delphi study
Viktor Grünwald, Axel Bex, Sylvie Rottey, et al.
BJU International
|
July 12, 2023
Diagnosis, treatment, and survival from kidney cancer: real-world National Health Service England data between 2013 and 2019
Samantha Conroy, James W F Catto, Axel Bex, et al.
Abdominal Radiology (New York)
|
June 22, 2020
Renal biopsies performed before versus during ablation of T1 renal tumors: implications for prevention of overtreatment and follow-up
Christiaan V Widdershoven, Brigitte M Aarts, Patricia J Zondervan, et al.
BMC Medicine
|
October 4, 2019
The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohort
Tobias Klatte, Kevin M Gallagher, Luca Afferi, et al.
World Journal of Urology
|
July 18, 2015
Neoadjuvant induction dose-dense MVAC for muscle invasive bladder cancer: efficacy and safety compared with classic MVAC and gemcitabine/cisplatin
Elisabeth E Fransen van de Putte, Laura S Mertens, Richard P Meijer, et al.
European Urology
|
February 4, 2025
Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitors and Subsequent Therapy for Renal Cell Carcinoma
Jens Bedke, Yasmin Abu Ghanem, Laurence Albiges, et al.
European Urology Oncology
|
December 12, 2024
Is Frequent Imaging Necessary? Impact of Computed Tomography During Follow-up After Surgical Treatment for Nonmetastatic Renal Cell Carcinoma: A Systematic Review
Luna van den Brink, Marlin A A Reijerink, Michael M E L Henderickx, et al.
European Urology
|
December 13, 2022
The 2022 Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitor Therapy for Renal Cell Carcinoma
Jens Bedke, Laurence Albiges, Umberto Capitanio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 11, 2012
Rapid angiogenesis onset after discontinuation of sunitinib treatment of renal cell carcinoma patients
Arjan W Griffioen, Laurie A Mans, Annemarie M A de Graaf, et al.
European Urology
|
May 17, 2020
Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic
Christopher J D Wallis, Giacomo Novara, Laura Marandino, et al.
Page
of 34
Search research articles
Search
Showing results (231-240 of 332) with videos related to
Sort By:
Page
of 34
European Journal of Cancer (Oxford, England : 1990)
|
June 14, 2025
Current status of adjuvant immunotherapy and relapse management in renal cell carcinoma: Insights from a European delphi study
Viktor Grünwald, Axel Bex, Sylvie Rottey, et al.
BJU International
|
July 12, 2023
Diagnosis, treatment, and survival from kidney cancer: real-world National Health Service England data between 2013 and 2019
Samantha Conroy, James W F Catto, Axel Bex, et al.
Abdominal Radiology (New York)
|
June 22, 2020
Renal biopsies performed before versus during ablation of T1 renal tumors: implications for prevention of overtreatment and follow-up
Christiaan V Widdershoven, Brigitte M Aarts, Patricia J Zondervan, et al.
BMC Medicine
|
October 4, 2019
The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohort
Tobias Klatte, Kevin M Gallagher, Luca Afferi, et al.
World Journal of Urology
|
July 18, 2015
Neoadjuvant induction dose-dense MVAC for muscle invasive bladder cancer: efficacy and safety compared with classic MVAC and gemcitabine/cisplatin
Elisabeth E Fransen van de Putte, Laura S Mertens, Richard P Meijer, et al.
European Urology
|
February 4, 2025
Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitors and Subsequent Therapy for Renal Cell Carcinoma
Jens Bedke, Yasmin Abu Ghanem, Laurence Albiges, et al.
European Urology Oncology
|
December 12, 2024
Is Frequent Imaging Necessary? Impact of Computed Tomography During Follow-up After Surgical Treatment for Nonmetastatic Renal Cell Carcinoma: A Systematic Review
Luna van den Brink, Marlin A A Reijerink, Michael M E L Henderickx, et al.
European Urology
|
December 13, 2022
The 2022 Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitor Therapy for Renal Cell Carcinoma
Jens Bedke, Laurence Albiges, Umberto Capitanio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 11, 2012
Rapid angiogenesis onset after discontinuation of sunitinib treatment of renal cell carcinoma patients
Arjan W Griffioen, Laurie A Mans, Annemarie M A de Graaf, et al.
European Urology
|
May 17, 2020
Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic
Christopher J D Wallis, Giacomo Novara, Laura Marandino, et al.
Page
of 34